Search
Sunday 31 May 2015
  • :
  • :

Yesterday’s Gainers in Focus - Media General, (NYSE:MEG), SunEdison, (NYSE:SUNE), Oncolytics Biotech, (NASDAQ:ONCY), KeyCorp, (NYSE:KEY)

On Thursday, Shares of Media General, Inc. (NYSE:MEG), surged 1.51% to $16.84.

Media General, declared Madeline Carino as the recipient of its 2015 Minority Broadcast Scholarship and Training Program and Giselle Johnson as the recipient of its 2015 Minority Digital Scholarship and Training Program.

Media General’s Minority Scholarship and Training Program is an integral part of the Company’s strategy to strengthen its talent base and deepen connections within its local communities by building on the cultural diversity of its workforce. Students are selected for the program based on various criteria, counting academic achievement, passion for broadcasting and digital screens, in addition to a strong desire to contribute to the overall advancement of the industry. Each student will receive either a one-year or two-year scholarship for up to ten thousand dollars ($10,000) per year. The Minority Scholarship and Training Program recipients will be assigned full-time positions at Media General upon graduation and successful completion of the training program.

Ms. Carino will be entering her senior year at Michigan State University, where she is pursuing a degree in Journalism. During her time at Michigan State University, Ms. Carino served as Section Editor for the university’s student-run publication; Student Assistant for the Michigan State University Communications Department and Student U Employee for the Big Ten Network, where she operated the camera for some of the university’s sports games and prepared graphics for broadcasts. She was also a freelance camera and graphics operator for PlayOn! Sports, which streams high school play-off games online. Ms. Carino has received numerous honors and awards at Michigan State University, counting achieving Dean’s List every semester since she began her college career and receiving the School of Journalism’s Wanda J. Herndon Scholarship. Ms. Carino will earn hands-on broadcast training this summer at one of Media General’s television stations.

Ms. Johnson will be entering her junior year at Howard University in Washington, D.C., where she is pursuing her Bachelor of Arts degree in Media, Journalism and Film Communications, with a minor in Theatre Arts. Since high school, Ms. Johnson has shown a strong interest in utilizing media on all screens for humanitarian causes. She was Founder and President of “Project Dream,” a film club dedicated to raising funds for children’s issues such as cancer and diabetes, and orphanages around the Houston community. She also established her own digital media company in 2013, known as ReelVintage Productions, where she directed a short film known as “COW,” which was selected for the 2014 International Black Women’s Film Festival. Ms. Johnson had the privilege of reporting on First Lady Michelle Obama at the White House and was able to attend Cannes Film Festival in France. In addition to all of her outstanding achievements, Ms. Johnson is also a part of the Annenberg Honors Program within Howard’s School of Communications. Ms. Johnson will continue to advance her career in digital media through a summer 2015 internship at one of Media General’s television stations or digital businesses.

Media General, Inc. owns and operates television stations in the United States. It operates 71 network-associated stations, and their associated digital media and mobile platforms, counting 22 CBS stations, 14 NBC stations, 12 ABC stations, 8 FOX stations, 7 MyNetworkTV stations, 7 CW stations, and 1 Telemundo station in 48 markets. Media General, Inc. was founded in 1850 and is headquartered in Richmond, Virginia.

Shares of SunEdison, Inc. (NYSE:SUNE), gained 1.50% to $27.07, during the last trading session on Thursday.

SunEdison, declared that Cathy Zoi has been designated Chief Executive Officer responsible for developing SunEdison’s rural electric utility company, which plans to profitably electrify 20 million new or underserved electric customers by 2020.

Cathy Zoi has spent 30 years in the energy and environmental sectors, both in business and public service. She was a partner at Silver Lake Kraftwerk, in addition to an operating executive in energy companies. Ms. Zoi was the founding CEO of the Alliance for Climate Protection, which she launched with former U.S. Vice President Al Gore, in addition to the CEO of the Sustainable Energy Development Authority, a fund to commercialize greenhouse-friendly technologies in Australia. She also served as Acting Under Secretary and Assistant Secretary in the U.S. Department of Energy in the Obama Administration and at the U.S. Environmental Protection Agency as a pioneer of the Energy Star Program. Ms. Zoi has a B.S. in Geology from Duke and an M.S. in Engineering from Dartmouth.

Ms. Zoi, who is presently a Consulting Professor at Stanford University, where she co-founded and directs the Energy Transformation Collaborative (ETC), will formally commence with SunEdison in June at the end of Stanford’s academic year.

SunEdison, Inc. develops, manufactures, and sells silicon wafers to the semiconductor industry. The company operates through three segments: Solar Energy, TerraForm Power, and Semiconductor Materials. The Solar Energy segment provides solar energy services that integrate the design, installation, financing, monitoring, operations, and maintenance portions of the downstream solar market. It also manufactures polysilicon, silicon wafers, and solar modules.

At the end of Thursday’s trade, Shares of Oncolytics Biotech Inc. (NASDAQ:ONCY), gained 1.47% to $0.69.

Oncolytics Biotech, declared that Dr. Matt Coffey, Chief Operating Officer, made a presentation titled “REOLYSIN® and Immune Therapy: Rationale for Combination Therapy” at the Royal Society of Medicine’s Immuno-oncology: Using the Body’s Own Weapons conference, held in London, UK. The presentation comprised of data from a single arm clinical study examining the use of REOLYSIN® in combination with gemcitabine in patients with advanced pancreatic cancer (REO 017), PD-1 and PD-L1 up regulation data from a single arm clinical study examining the use of REOLYSIN® in patients with primary glioblastomas or brain metastases (REO 013b), in addition to preclinical data.

Highlights of new data presented comprise:

  • Clinical evidence that REOLYSIN® treatment results in immunological changes to both the tumor cells and the tumor microenvironment that is conducive to novel immune targeting interventions; and
  • Updated results from the REO 017 study, in which pancreatic cancer patients received combination therapy with REOLYSIN® and gemcitabine demonstrated a median overall survival (OS) of 10.2 months, and one- and two-year survival rates of 45% and 24%, respectively.

Oncolytics Biotech Inc., a development stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancers. The company develops REOLYSIN, a cancer therapeutic that is in various clinical trials for human use. Its cancer product is a potential therapeutic for tumours possessing an activated Ras pathway. The company was founded in 1998 and is headquartered in Calgary, Canada.

Finally, KeyCorp. (NYSE:KEY), ended its Thursday’s trading session with 1.48% gain, and closed at $14.40.

KeyCorp, declared first quarter net income from ongoing operations attributable to Key common shareholders of $222 million, or $.26 per common share, contrast to $246 million, or $.28 per common share, for the fourth quarter of 2014, and $232 million, or $.26 per common share, for the first quarter of 2014.

In the first quarter of 2015, Key had average assets of $91.9 billion contrast to $90.2 billion in the first quarter of 2014 and $91.1 billion in the fourth quarter of 2014. Contrast to the first quarter of 2014, average loans grew 5.1% to $57.5 billion while average deposits grew 4.9% to $68.8 billion. In addition, Key’s average total investment securities raised, with a higher percentage of Ginnie Mae securities, as Key continued to position the portfolio for forthcoming regulatory liquidity requirements.

Average loans were $57.5 billion for the first quarter of 2015, an raise of $2.8 billion contrast to the first quarter of 2014. The loan growth occurred primarily in the commercial, financial and agricultural portfolio, which raised $2.9 billion and was broad-based across Key’s commercial lines of business. Consumer loans remained relatively stable as modest raises across Key’s core consumer loan portfolio were offset by run-off in Key’s consumer exit portfolios.

Contrast to the fourth quarter of 2014, average loans raised by $971 million, driven by commercial, financial and agricultural loans, which raised by $1.1 billion. On a period-end basis, commercial, financial and agricultural loans raised $801 million over the linked quarter driven by strong demand that carried over from the fourth quarter of 2014.

KeyCorp operates as the bank holding company for KeyBank National Association that provides various retail and commercial banking services to individual, corporate, and institutional clients in the United States.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content comprised of in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve talk aboutions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as anticipates, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.




Leave a Reply

Your email address will not be published. Required fields are marked *